Pfizer Chairman and CEO Hank McKinnell sees the company's $58 billion blockbuster acquisition of Pharmacia as the key to Pfizer's leadership in pharmaceutical markets around the globe.
Franklin Lakes, New Jersey-Merck’s pharmacy benefit arm, Merck-Medco, is under fire for switching patients to more expensive pharmaceuticals.
As healthcare struggles to reinvent itself, a confluence of major societal forces has irrevocably changed both the business world and the healthcare landscape.
FDA's Final Rule Forces the Pharma Industry to Change It's Clinical Trial Culture
Reps need to spend time planning, account targeting and learning about new managed care tools that drive today's operations as well as prepare us for tomorrow's growth businesses.
Despite the investment in place, industry still struggles to take advantage of competitive intelligence as key decision aid.
A rep's guide to retirement investing.
Physicians give only 25 percent of samples to newly diagnosed patients, along with a prescription.
Reps can make a better impact by managing the time they have.
China's large patient base and concentrated specialty hospitals make it easier to recruit patients for clinical trials in than in the United States. On average, companies can save from two to five months by conducting a Phase I study in China.
Aside from helping the prospects and customers succeed at what they do or want to do, salespeople are most interested in one specific behavior change: compliance to a request. In generating a positive response, six basic tendencies of human behavior take the stage: reciprocation, consistency, social validation, liking, authority and scarcity. The more of the six following persuasion influencers a salesperson uses in his or her presentation and selling approach, the greater his or her chances of closing the sale:
Having so many retirement choices shouldn't leave you wondering which type of retirement savings plan is best for you.
From her start as a physician working in apartheid-era South Africa to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.
The growing number of foreign-born physicians in the United States presents both challenges and opportunities for pharmaceutical sales representatives.
The US drug regulatory system fails to address the country’s most urgent medical needs with the resources appropriate for the task. But change is possible, say Christopher-Paul Milne and Kenneth I. Kaitin.